Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Xiong D, He H, James J, Tokunaga C, Powers C, Huang Y, Osinska H, Towbin JA, Purevjav E, Balschi JA, Javadov S, McGowan FX Jr, Strauss AW, Khuchua Z.

Am J Physiol Heart Circ Physiol. 2014 Feb;306(3):H326-38. doi: 10.1152/ajpheart.00931.2012. Epub 2013 Nov 27.

2.

Development and pathomechanisms of cardiomyopathy in very long-chain acyl-CoA dehydrogenase deficient (VLCAD(-/-)) mice.

Tucci S, Flögel U, Hermann S, Sturm M, Schäfers M, Spiekerkoetter U.

Biochim Biophys Acta. 2014 May;1842(5):677-85. doi: 10.1016/j.bbadis.2014.02.001. Epub 2014 Feb 12.

3.
4.

Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.

Diekman EF, van Weeghel M, Wanders RJ, Visser G, Houten SM.

FASEB J. 2014 Jul;28(7):2891-900. doi: 10.1096/fj.14-250241. Epub 2014 Mar 19.

5.

Prolonged QT interval and lipid alterations beyond β-oxidation in very long-chain acyl-CoA dehydrogenase null mouse hearts.

Gélinas R, Thompson-Legault J, Bouchard B, Daneault C, Mansour A, Gillis MA, Charron G, Gavino V, Labarthe F, Des Rosiers C.

Am J Physiol Heart Circ Physiol. 2011 Sep;301(3):H813-23. doi: 10.1152/ajpheart.01275.2010. Epub 2011 Jun 17.

6.

Long-term correction of very long-chain acyl-coA dehydrogenase deficiency in mice using AAV9 gene therapy.

Keeler AM, Conlon T, Walter G, Zeng H, Shaffer SA, Dungtao F, Erger K, Cossette T, Tang Q, Mueller C, Flotte TR.

Mol Ther. 2012 Jun;20(6):1131-8. doi: 10.1038/mt.2012.39. Epub 2012 Mar 6.

7.

Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase.

Exil VJ, Gardner CD, Rottman JN, Sims H, Bartelds B, Khuchua Z, Sindhal R, Ni G, Strauss AW.

Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1289-97. Epub 2005 Sep 30.

8.

De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.

Tucci S, Behringer S, Spiekerkoetter U.

FEBS J. 2015 Nov;282(21):4242-53. doi: 10.1111/febs.13418. Epub 2015 Sep 11.

PMID:
26284828
9.

Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.

Wood JC, Magera MJ, Rinaldo P, Seashore MR, Strauss AW, Friedman A.

Pediatrics. 2001 Jul;108(1):E19.

PMID:
11433098
10.

Gestational, pathologic and biochemical differences between very long-chain acyl-CoA dehydrogenase deficiency and long-chain acyl-CoA dehydrogenase deficiency in the mouse.

Cox KB, Hamm DA, Millington DS, Matern D, Vockley J, Rinaldo P, Pinkert CA, Rhead WJ, Lindsey JR, Wood PA.

Hum Mol Genet. 2001 Sep 15;10(19):2069-77.

11.

Synergistic heterozygosity in mice with inherited enzyme deficiencies of mitochondrial fatty acid beta-oxidation.

Schuler AM, Gower BA, Matern D, Rinaldo P, Vockley J, Wood PA.

Mol Genet Metab. 2005 May;85(1):7-11. Epub 2005 Feb 16.

PMID:
15862275
12.

Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.

Primassin S, Tucci S, Spiekerkoetter U.

Mol Genet Metab. 2011 Dec;104(4):546-51. doi: 10.1016/j.ymgme.2011.09.011. Epub 2011 Sep 16.

PMID:
21963783
13.

Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.

Spiekerkoetter U, Tokunaga C, Wendel U, Mayatepek E, Ijlst L, Vaz FM, van Vlies N, Overmars H, Duran M, Wijburg FA, Wanders RJ, Strauss AW.

Pediatr Res. 2005 Jun;57(6):760-4. Epub 2005 Mar 17.

PMID:
15774826
14.

Stressed-induced TMEM135 protein is part of a conserved genetic network involved in fat storage and longevity regulation in Caenorhabditis elegans.

Exil VJ, Silva Avila D, Benedetto A, Exil EA, Adams MR, Au C, Aschner M.

PLoS One. 2010 Dec 3;5(12):e14228. doi: 10.1371/journal.pone.0014228.

15.

Long-chain fatty acid oxidation during early human development.

Oey NA, den Boer ME, Wijburg FA, Vekemans M, Augé J, Steiner C, Wanders RJ, Waterham HR, Ruiter JP, Attié-Bitach T.

Pediatr Res. 2005 Jun;57(6):755-9. Epub 2005 Apr 21.

PMID:
15845636
16.

Mitochondrial fatty acid oxidation disorders: pathophysiological studies in mouse models.

Spiekerkoetter U, Wood PA.

J Inherit Metab Dis. 2010 Oct;33(5):539-46. doi: 10.1007/s10545-010-9121-7. Epub 2010 Jun 8. Review.

17.
18.

Cardiac hypertrophy in mice with long-chain acyl-CoA dehydrogenase or very long-chain acyl-CoA dehydrogenase deficiency.

Cox KB, Liu J, Tian L, Barnes S, Yang Q, Wood PA.

Lab Invest. 2009 Dec;89(12):1348-54. doi: 10.1038/labinvest.2009.86. Epub 2009 Sep 7.

19.

Biochemical correction of very long-chain acyl-CoA dehydrogenase deficiency following adeno-associated virus gene therapy.

Merritt JL 2nd, Nguyen T, Daniels J, Matern D, Schowalter DB.

Mol Ther. 2009 Mar;17(3):425-9. doi: 10.1038/mt.2008.295. Epub 2009 Jan 20.

20.

Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.

Tenopoulou M, Chen J, Bastin J, Bennett MJ, Ischiropoulos H, Doulias PT.

J Biol Chem. 2015 Apr 17;290(16):10486-94. doi: 10.1074/jbc.M114.635102. Epub 2015 Mar 3.

Items per page

Supplemental Content

Write to the Help Desk